Key result
Editorial reviews perioperative hydroxyethyl starch use without providing definitive clinical outcome data.
No clinical data presented; leaves open perioperative hydroxyethyl starch safety and efficacy.
From the *Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany †Division of Anesthesiology, Perioperative Medicine, Emergency and Critical Care Medicine, Maastricht University Medical Center, Maastricht, the Netherlands. Accepted for publication December 6, 2021. Funding: This study was supported by the Deutsche Forschungsgemeinschaft (KFO342-1, ZA428/18-1, and ZA428/21-1 to A.Z.). Conflicts of Interest: See Disclosures at the end of the article. Reprints will not be available from the authors. Address correspondence to Alexander Zarbock, MD, Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Gebäude A1, Münster 48149, Germany. Address e-mail to [email protected].
No takes yet. Share an insight, caveat, or question.
Zarbock et al. (2022) reported an editorial. Hydroxyethyl Starch was evaluated. Hydroxyethyl starch in the perioperative period is discussed, but the abstract provides no clinical data or quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: